Gabapentin Tablet
Product Images NDC 16571-226

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 16571-226). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (06f8005c B5be 4875 B0c2 61f5fcbe62c4 01)

Chemical structure of the active ingredient Gabapentin, showing its molecular configuration with an amino group, a carboxylic acid group, and a cyclohexane ring.*

FDA Label Image

Image (06f8005c B5be 4875 B0c2 61f5fcbe62c4 02)

A line graph depicting mean pain scores over an 8-week period comparing Gabapentin 3600 mg/day with placebo. The x-axis represents weeks, including a 4-week dose titration and a 4-week fixed dose period, while the y-axis shows mean pain scores from 0 to 10. Gabapentin shows a decreasing trend in pain score compared to the relatively stable pain score of placebo.*

FDA Label Image

Image (06f8005c B5be 4875 B0c2 61f5fcbe62c4 03)

A line graph showing mean pain score over seven weeks for placebo and two dosages of gabapentin (1800 mg/day and 2400 mg/day). The x-axis represents weeks from baseline to week 7, and the y-axis represents mean pain score from 0 to 10. The chart includes a 3-week dose titration period and a 4-week fixed dose period.*

FDA Label Image

Image (06f8005c B5be 4875 B0c2 61f5fcbe62c4 04)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) at different doses in two studies. Study 1 shows 12% responders for placebo and 29% for GBP 3600 mg. Study 2 shows 14% responders for placebo, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance is indicated with p-values below 0.01 and 0.001.*

FDA Label Image

Image (06f8005c B5be 4875 B0c2 61f5fcbe62c4 05)

A scatter plot comparing percentage difference against daily dose in milligrams from three studies labeled as Study a, Study b, and Study c. The daily doses range from about 600 mg to 1800 mg, with percentage differences shown on the vertical axis.*

FDA Label Image

Image (06f8005c B5be 4875 B0c2 61f5fcbe62c4 06)

Gabapentin Tablets, USP 600 mg oral tablets label from Rising Pharma Holdings, Inc. The package contains 100 tablets and is marked Rx only. The label states to dispense the accompanying medication guide, storage instructions with temperature range, and includes manufacturing information for Graviti Pharmaceuticals Pvt. Ltd. in India, along with a barcode and revision date 03/2024.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.